Cargando…
Putative BRAF activating fusion in a medullary thyroid cancer
Medullary thyroid cancer (MTC) is a malignancy of the calcitonin-producing parafollicular cells of the thyroid gland. Surgery is the only curative treatment for this cancer. External beam radiation therapy is reserved for adjuvant treatment of MTC with aggressive features. Targeted therapeutics vand...
Autores principales: | Kasaian, Katayoon, Wiseman, Sam M., Walker, Blair A., Schein, Jacqueline E., Hirst, Martin, Moore, Richard A., Mungall, Andrew J., Marra, Marco A., Jones, Steven J.M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4849853/ https://www.ncbi.nlm.nih.gov/pubmed/27148585 http://dx.doi.org/10.1101/mcs.a000729 |
Ejemplares similares
-
The genomic and transcriptomic landscape of anaplastic thyroid cancer: implications for therapy
por: Kasaian, Katayoon, et al.
Publicado: (2015) -
A BRAF V600E Mutation in RET-Negative Medullary Thyroid Cancer
por: Robbins, Richard J., et al.
Publicado: (2020) -
Medullary thyroid carcinoma: recent advances in identification,
treatment, and prognosis
por: Bartz-Kurycki, Marisa A., et al.
Publicado: (2021) -
Clinical outcomes after whole-genome sequencing in patients with metastatic non-small-cell lung cancer
por: Tsang, Erica S., et al.
Publicado: (2019) -
BRAF Mutation in Colorectal Rhabdoid and Poorly Differentiated Medullary Carcinomas
por: Bolzacchini, Elena, et al.
Publicado: (2019)